In the current political climate, it is rare to see legislators from both sides of the aisle agree on an issue. However, Congress has been united in the dire need for reforms to address prescription drug middlemen known as pharmacy benefit managers (PBMs). Members from both parties have been expressing serious concerns about the role […]
Author Archives: Carl Schmid
Carl Schmid is the executive director of the HIV+Hepatitis Policy Institute. He wrote this for InsideSources.com.